Chairs

  • Fatima Cardoso, ESO Breast Cancer Programme Coordinator and Champalimaud Cancer Center, Lisbon, PT
  • Alexandru Eniu, ESO and Cancer Institute « I. Chiricuta”, Cluj-Napoca, RO
  • Jens Huober, Ulm University Hospital, Ulm, DE
  • Wolfgang Janni, Ulm University Hospital, Ulm, DE
  • Olivia Pagani, ESO and Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
  • Hope Rugo, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, US

Overall Scientific Director

  • Olivia Pagani, ESO and Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH

Scientific Directors

  • Jack Cuzick, Centre for Cancer Prevention, Queen Mary University of London, London, UK
  • Oreste Gentilini, European Institute of Oncology, Milan, IT
  • Nadia Harbeck, Hospital of the University of Munich (LMU), Breast Centre, Dept. of Obstetrics and Gynaecology, Munich, DE
  • Volkmar Müller, University Medical Center Hamburg-Eppendorf, Gynecology-Oncology Department, Hamburg, DE
  • Tibor Tot, Department of Pathology and Clinical Cytology, Central Hospital Falun, Falun, SE

Conceptual Development and Organisation

  • Uta Schmidt-Strassburger, Ulm University Hospital, Ulm, DE
  • Alexandra Zampetti, ESO, Bellinzona, CH

CCB3 Curriculum Overview